Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis

Biedermann A, Mangelberger-Eberl D, Mougiakakos D, Büttner-Herold M, Flamann C, Kellner C, Altmeyer S, Bittenbring J, Augsberger C, Patra-Kneuer M, Landgraf K, Ilieva-Babinsky K, Haskamp S, Beier F, Völkl S, Pallasch C, Jacobs B, Steidl S, Heitmueller C, Mackensen A, Bruns H (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Blood American Society of Hematology

Publisher: AMER SOC HEMATOLOGY

City/Town: WASHINGTON

Pages Range: 9292-9293

Conference Proceedings Title: BLOOD

DOI: 10.1182/blood-2022-159955

Authors with CRIS profile

Maike Büttner-Herold Department of Nephropathology Cindy Flamann Department of Medicine 5 – Haematology and Oncology Simon Völkl Department of Medicine 5 – Haematology and Oncology Benedikt Jacobs Department of Medicine 5 – Haematology and Oncology Andreas Mackensen Lehrstuhl für Innere Medizin V Heiko Bruns Department of Medicine 5 – Haematology and Oncology

Involved external institutions

MorphoSys AG DE Germany (DE) Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen DE Germany (DE) Otto-von-Guericke-Universität Magdeburg DE Germany (DE) Universitätsklinikum des Saarlandes (UKS) DE Germany (DE) Ludwig-Maximilians-Universität (LMU) DE Germany (DE) Universitätsklinikum Köln DE Germany (DE) Universität des Saarlandes (UdS) DE Germany (DE)

How to cite

APA:

Biedermann, A., Mangelberger-Eberl, D., Mougiakakos, D., Büttner-Herold, M., Flamann, C., Kellner, C.,... Bruns, H. (2022). Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis. In BLOOD (pp. 9292-9293). WASHINGTON: AMER SOC HEMATOLOGY.

MLA:

Biedermann, Alexander, et al. "Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2022. 9292-9293.

BibTeX: Download